Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,744
Closed -$270K 153
2025
Q2
$270K Buy
+2,744
New +$260K ﹤0.01% 97
2024
Q4
Sell
-10,072
Closed -$972K 130
2024
Q3
$972K Buy
+10,072
New +$983K 0.01% 140
2024
Q2
Sell
-6,978
Closed -$643K 440
2024
Q1
$643K Buy
+6,978
New +$654K 0.01% 103
2023
Q3
Sell
-1,794,000
Closed -$164M 90
2023
Q2
$164M Buy
1,794,000
+310,821
+21% +$25.5M 3.5% 4
2023
Q1
$109M Buy
1,483,179
+347,099
+31% +$30M 2.43% 10
2022
Q4
$94.9M Buy
1,136,080
+776,315
+216% +$70M 1.96% 17
2022
Q3
$34.8M Buy
359,765
+160,765
+81% +$19.2M 0.69% 49
2022
Q2
$20.9M Buy
+199,000
New +$25.4M 0.43% 60
2014
Q3
Sell
-81,399
Closed -$1.36M 133
2014
Q2
$1.36M Sell
81,399
-357,601
-81% -$5.07M 0.05% 107
2014
Q1
$6.54M Buy
+439,000
New +$6.76M 0.27% 82
2013
Q3
Sell
-233,066
Closed -$2.7M 116
2013
Q2
$2.7M Buy
+233,066
New +$2.67M 0.13% 86

Other funds holding AMED

Deerfield Management's AMED Position: Q3 2025 in Review

Deerfield Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 2,744 shares — an estimated $270K sold.

Deerfield Management first reported a position in AMED in Q2 2013 and held it in 11 quarters. The position peaked at $164M in Q2 2023. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Deerfield Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Deerfield Management sold 2,744 Amedisys shares in Q3 2025, an estimated $270K.
  • Deerfield Management first reported a position in Amedisys in Q2 2013 and held it in 11 quarters.
  • Deerfield Management's Amedisys position peaked at $164M in Q2 2023.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Deerfield Management's 13F filing for Q3 2025, filed 14 Nov 2025.